30Jul
Increased regulatory scrutiny of foreign direct investments in the healthcare sector
Key Takeaways - - Foreign Direct Investment (FDI) controls are proliferating around the globe. Since the pandemic, “health” has become a particular focus. - Several countries have adapted their existing FDI rules, or introduced new ones, to address concerns about national autonomy and supply chain disruption. Some of these changes are general, but some are specific to healthcare. - Plans for cross-border M&A in the healthcare sector should take close account of potential FDI screening...
By:
Dechert LLP
Related
Quick Hit: Effective October 1, 2019, Maryland law prohibits the use of non-competition agreements f...
Read More >
It is without question that changes to present-day life caused by the spread of COVID-19 are both ma...
Read More >
SB 977 was passed by the California Senate on June 26, 2020. If the bill is passed by the Assembly a...
Read More >
A recent decision from the Colorado Court of Appeals clarifies that employers can limit the payment ...
Read More >
In Channel Medsystems, Inc. v. Boston Scientific Corporation, the Delaware Court of Chancery rejecte...
Read More >
On October 10, 2019, California Governor Gavin Newsom signed into law California Assembly Bill 51 (“...
Read More >